Character Bio is a company headquartered in Israel.
Character Bio is a precision medicine company that analyzes genetic, imaging, and clinical data to model progression of progressive polygenic eye diseases, initially focusing on dry age-related macular degeneration (AMD), to develop targeted therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.